Fc-Associated Effector Functions CH 2 Domain of Murine IgG 1 on Impact of a Three Amino Acid Deletion in the Nishimura

[1]  J. Ravetch,et al.  Differential Contribution of Three Activating IgG Fc Receptors (FcγRI, FcγRIII, and FcγRIV) to IgG2a- and IgG2b-Induced Autoimmune Hemolytic Anemia in Mice1 , 2008, The Journal of Immunology.

[2]  M. Nakano,et al.  Comprehensive approach to structural and functional glycomics based on chemoselective glycoblotting and sequential tag conversion. , 2008, Analytical chemistry.

[3]  A. Blom,et al.  Endoglycosidase treatment abrogates IgG arthritogenicity: Importance of IgG glycosylation in arthritis , 2007, European journal of immunology.

[4]  Yoshiaki Miura,et al.  Quantitative Glycomics of Human Whole Serum Glycoproteins Based on the Standardized Protocol for Liberating N-Glycans *S , 2007, Molecular & Cellular Proteomics.

[5]  Y. Miura,et al.  Rapid and simple solid-phase esterification of sialic acid residues for quantitative glycomics by mass spectrometry. , 2007, Chemistry.

[6]  J. Ravetch,et al.  Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity , 2007, Proceedings of the National Academy of Sciences.

[7]  J. Ravetch,et al.  Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation , 2006, Science.

[8]  M. Madaio,et al.  The Journal of Experimental Medicine CORRESPONDENCE , 2005 .

[9]  J. Ravetch,et al.  Divergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding , 2005, Science.

[10]  Hiroaki Nakagawa,et al.  High Throughput Quantitative Glycomics and Glycoform-focused Proteomics of Murine Dermis and Epidermis* , 2005, Molecular & Cellular Proteomics.

[11]  P. Bruhns,et al.  FcγRIV : A novel FcR with distinct IgG subclass specificity , 2005 .

[12]  M. Walport,et al.  Complement Activation Selectively Potentiates the Pathogenicity of the IgG2b and IgG3 Isotypes of a High Affinity Anti-Erythrocyte Autoantibody , 2002, The Journal of experimental medicine.

[13]  M. Walport,et al.  Reconstitution of the Complement Function in C1q-Deficient (C1qa−/−) Mice with Wild-Type Bone Marrow Cells1 , 2001, The Journal of Immunology.

[14]  P. Parren,et al.  The IgG Fc Contains Distinct Fc Receptor (FcR) Binding Sites: The Leukocyte Receptors FcγRI and FcγRIIa Bind to a Region in the Fc Distinct from That Recognized by Neonatal FcR and Protein A1 , 2000, The Journal of Immunology.

[15]  T. Honjo,et al.  High Pathogenic Potential of Low-Affinity Autoantibodies in Experimental Autoimmune Hemolytic Anemia , 1999, The Journal of experimental medicine.

[16]  R. Schmidt,et al.  FcγRIII (CD16)-Deficient Mice Show IgG Isotype-Dependent Protection to Experimental Autoimmune Hemolytic Anemia , 1998 .

[17]  R. Jefferis,et al.  Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc gamma receptor I and influence the synthesis of its oligosaccharide chains. , 1996, Journal of immunology.

[18]  R. Schmidt,et al.  Impaired IgG-Dependent Anaphylaxis and Arthus Reaction in FcγRIII (CD16) Deficient Mice , 1996 .

[19]  M. Ono,et al.  Augmented humoral and anaphylactic responses in FcγRII-deficient mice , 1996, Nature.

[20]  R. Dwek,et al.  Glycosylation changes of IgG associated with rheumatooid arthritis can activate complement via the mannose-binding protein , 1995, Nature Medicine.

[21]  S L Morrison,et al.  Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1 , 1994, The Journal of experimental medicine.

[22]  J. Ravetch,et al.  FcR γ chain deletion results in pleiotrophic effector cell defects , 1994, Cell.

[23]  S. Morrison,et al.  Structural features of human immunoglobulin G that determine isotype- specific differences in complement activation , 1993, The Journal of experimental medicine.

[24]  M. Klein,et al.  Identification of the Fc gamma receptor class I binding site in human IgG through the use of recombinant IgG1/IgG2 hybrid and point-mutated antibodies. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Morrison,et al.  The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region , 1991, The Journal of experimental medicine.

[26]  T. Berney,et al.  Monoclonal anti-erythrocyte autoantibodies derived from NZB mice cause autoimmune hemolytic anemia by two distinct pathogenic mechanisms. , 1990, International immunology.

[27]  K. Titani,et al.  Structural changes in the oligosaccharide chains of IgG in autoimmune MRL/Mp-lpr/lpr mice. , 1990, Journal of immunology.

[28]  D. Sears,et al.  Molecular cloning and expression of the mouse high affinity Fc receptor for IgG. , 1990, Journal of immunology.

[29]  S. Ho,et al.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction. , 1989, Gene.

[30]  J. Ravetch,et al.  Function and regulation of a murine macrophage-specific IgG Fc receptor, Fc gamma R-alpha , 1988, The Journal of experimental medicine.

[31]  G. Winter,et al.  The binding site for C1q on IgG , 1988, Nature.

[32]  D. Burton,et al.  Localization of the binding site for the human high-affinity Fc receptor on IgG , 1988, Nature.

[33]  R. Dwek,et al.  Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG , 1985, Nature.

[34]  H. Wigzell,et al.  Biological significance of carbohydrate chains on monoclonal antibodies. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Pepys,et al.  Activation of mouse complement by different classes of mouse antibody. , 1979, Immunology.

[36]  J. Ravetch,et al.  Fcgamma receptors: old friends and new family members. , 2006, Immunity.

[37]  Hiroaki Nakagawa,et al.  High-throughput protein glycomics: combined use of chemoselective glycoblotting and MALDI-TOF/TOF mass spectrometry. , 2004, Angewandte Chemie.